Clinical Trial Update: Aplidin - Dexamethasone in Relapsed/Refractory Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial update on Aplidin (plitidepsin) plus dexamethasone in relapsed/refractory multiple myeloma; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Aplidin (plitidepsin)
• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: PharmaMar | Conditions: Relapsed/Refractory Multiple Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2020-10-22